南微医学收盘上涨3.46%，滚动市盈率23.21倍，总市值132.47亿元

Company Overview - Nanwei Medical's closing price on July 4 was 70.52 yuan, an increase of 3.46%, with a rolling PE ratio of 23.21, marking a new low in 87 days, and a total market capitalization of 13.247 billion yuan [1] - The company specializes in the research, development, manufacturing, and sales of minimally invasive medical devices, with key products including biopsy, hemostasis, closure, EMR/ESD, dilation, ERCP, EUS/EBUS devices, ablation instruments, disposable imaging systems, and related consumables [1] Financial Performance - For Q1 2025, Nanwei Medical reported revenue of 699 million yuan, a year-on-year increase of 12.75%, and a net profit of 161 million yuan, also up 12.18%, with a gross profit margin of 65.69% [1] Shareholder Information - As of March 31, 2025, the number of shareholders in Nanwei Medical was 13,313, an increase of 639 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 51.05, with a median of 36.62, placing Nanwei Medical at the 50th position in the industry ranking [1][2] - The static PE ratio for Nanwei Medical is 23.94, and the price-to-book ratio is 3.32 [2]